• Home
  • Investors
    • News Archive
    • Share Information
      • Shareholder Service
      • General Meetings
    • Reports
    • Board and Management
  • Contact

You are here

Home » Investors

News

NorDiag ASA grants license to Institute Pasteur de Lille, France
Subscription of NorDiag shares starts today
Approved Prospectus
Oslo Børs - NORD T - Listed tomorrow
First NorDiag contract in US
Option scheme for employees in NorDiag
Ex subscription rights today
Extraordinary General Meeting held in NorDiag
Børsmelding fra Novel Diagnostics vedr NorDiag
Notice of Extraordinary General Meeting
Proposed rights issue
The results for Q1 2008 - Sales growth in the infectious diseases segment
NorDiag acquires exclusive rights to infectious disease technology platform
NorDiag expands collaboration with EXACT Sciences for joint development of colorectal cancer screening technologies
Presentation of the first quarter 2008
Protocol from Annual General Meeting
Annual overview
Notice of General Meeting
Financial Statements 2007
News from NorDiag's collaboration partner

Pages

  • « first
  • ‹ previous
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • next ›
  • last »
News archive

NORDA ASA  ♦  Stortingsgaten 28  ♦   0161 Oslo  ♦   Norway  ♦   Phone: +47 924 23 561  ♦   web: www.nordasa.no